McTiernan; Charles F.

Patent Applications and Registrations

Patent applications and USPTO patent grants for McTiernan; Charles F..The latest application filed is for "use of relaxin to treat atrial fibrillation".

Company Profile

2.4.10

McTiernan; Charles F. - Pittsburgh PA
McTiernan; Charles F - Pittsburgh PA
McTiernan; Charles F. - West View PA

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Use Of Relaxin To Treat Atrial Fibrillation App 20220289809 - Schwartzman; David S. ; et al.	2022-09-15
Microbubble Nucleic Acid Delivery Platform App 20200214973 - Villanueva; Flordeliza ; et al.	2020-07-09
Use Of Relaxin To Treat Atrial Fibrillation App 20200087371 - Schwartzman; David S. ; et al.	2020-03-19
Methods for creating a transgenic cell with microbubbles Grant 10,588,853 - Villanueva , et al.	2020-03-17
Custom Designed Microbubble Contrast Agents And Techniques Of Ultrasound Delivery Optimized For Nucleic Acid Delivery To Alter Gene Expression App 20180140542 - Villanueva; Flordeliza ; et al.	2018-05-24
Polymer Microbubbles As X-ray Dark Field Contrast Agents App 20170368204 - Villanueva; Flordeliza S. ; et al.	2017-12-28
Custom designed microbubble contrast agents and techniques of ultrasound delivery optimized for gene therapy Grant 9,844,504 - Villanueva , et al. December 19, 2	2017-12-19
Use Of Relaxin To Treat Atrial Fibrillation App 20170342120 - Schwartzman; David S. ; et al.	2017-11-30
Use Of Relaxin To Treat Atrial Fibrillation App 20150232526 - Schwartzman; David S. ; et al.	2015-08-20
Custom Designed Microbubble Contrast Agents And Techniques Of Ultrasound Delivery Optimized For Gene Therapy App 20130204166 - Villanueva; Florideliza ; et al.	2013-08-08
Transgenic mice containing a nucleic acid encoding tumor necrosis factor-.alpha. under the control of a cardiac specific regulatory region Grant 5,917,123 - McTiernan , et al. June 29, 1	1999-06-29

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.